Overview

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

Status:
Completed
Trial end date:
2012-05-19
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Pharmaceutical Solutions